Environment and Pollution Archives - Willingsford Healthcare

About
How to Use
- How to use Amicapsil
- How to use SertaSil
Technology
- MPPT – micropore particle technology
SCI
Wounds
- Amicapsil – Humans
- SertaSil – Animals
Dermatology
- Aprobaxil – Humans
- Adinasil – Animals
Sustainability
- Sustainability
- Environment and Climate Change
Info
Shop

About
How to Use
- How to use Amicapsil
- How to use SertaSil
Technology
- MPPT – micropore particle technology
SCI
Wounds
- Amicapsil – Humans
- SertaSil – Animals
Dermatology
- Aprobaxil – Humans
- Adinasil – Animals
Sustainability
- Sustainability
- Environment and Climate Change
Info
Shop

Close this search box.

MPPT – Frontiers in Medicine

New MPPT clinical study:
100% closure rate of pressure ulcers

Download Publication

Slider-web-60%

MPPT removes wound infections 60%
quicker than antibiotics and antiseptics.

Effective on resistant infections and does not contribute to AMR.

Slider-web-passive-immunotherapy

Passive Immunotherapy

acting via the skin and wound microbiome without the use of antimicrobials.

Slider-web-pain-etc

Amicapsil and Amicapsil-SCI

Effective wound treatment in immunocompetent and immunocompromised persons

Slider-web-1

Less Scarring

“Where I have used Acapsil the scarring is flat, whereas the older scars are hypertrophic.” Patient ST

“Where I have used Acapsil the scarring is flat against the surrounding skin, whereas the older scars are bulging / hypertrophic.” Patient ST

“Where I have used Aprobaxil the scarring is flat against the surrounding skin, whereas the older scars are bulging / hypertrophic.” Patient ST

Slider-web-1 – NH

“Amicapsil changed my life.”

“From 4 weeks of absolute hell – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

NH ( patient)

Slider-web-15

69.5% Savings

Cost-effectiveness determined in NHS Clinical Audit

Slider-web-hypoallergenic

Hypoallergenic

Only natural ingredients

Slider-web-FDA

FDA concluded in 2022:

Standard wound products, including antimicrobials, are ineffective.

US FDA 2016

Verma et al. (2022)

Slider-web-AMR

Amicapsil-SCI

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis.

Slider-web-AMR

Antimicrobials are environmentally unsustainable and contribute to climate change.
MPPT removes infections without the use of antimicrobials.

Slider-web-No-brainer

“For me, this Amicapsil open air method is a no brainer. It is easier, no fuss, and obviously cheaper than these expensive dressings.”

VH (patient)

Slider-web-Pollution

MPPT is environmentally sustainable:
it is biologically recyclable and does not require the use of chemicals, plastics or antimicrobials.

Pollution – Plastics, Antimicrobials & Chemicals

Currently, there are 278 million annual wound dressing changes in UK primary care. Most dressing changes include the use of wound cleaning solutions and dressings,

Willingsford Limited

NFEC, Rushington Business Park

Chapel Lane, Totton

Southampton SO40 9LA, United Kingdom

Phone: +44(0)23 8081 2325

E-mail: contact @ willingsford.com

News

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

January 5’th, 2024 – MPPT clinical study published in Frontiers in Medicine

October 8’th to 11’th, 2023 – Spinal Injuries Association presents poster on Amicapsil at the annual ISCoS meeting.

August 19, 2023 – Petition to make Amicapsil-SCI available on prescription.

Name

Message